Thomas P. Soloway

Insider Reports History

Entity
Individual
Location
C/O Audentes Therapeutics, Inc., 600 California St., 17 Th Floor, San Francisco, CA
Signature
/s/ Christopher Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas P. Soloway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Third Harmonic Bio, Inc. Director Director Stock Option (right to buy) 20K Jun 6, 2024 Direct
Satsuma Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by Thomas P. Soloway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
THRD Third Harmonic Bio, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 8, 2023 3 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Mar 6, 2023 4 $0 4 Mar 8, 2023 Director
THRD Third Harmonic Bio, Inc. Oct 26, 2022 1 $0 4 Oct 27, 2022 Director
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director